JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B1622 SGI-1027
4 Citation

Summary: DNMT inhibitor

≥22.25 mg/mL
B1252 Tenofovir hydrate

Summary: Reverse transcriptase inhibitor

Soluble in DMSO
A4613 HDAC8-IN-1

≥21.35 mg/mL
A8969 Naquotinib

Soluble in DMSO
C7007 D-3-Phenyllactic acid

≥31.2 mg/mL
BA2485 Mal-PEG1-Val-Cit-PABC-OH

Summary: Can be used to synthesize antibody-coupled reactive molecules (ADCs).
SL1022 Diethylstilbestrol-d4

Summary: A stable isotope deuterated compound of Diethylstilbestrol (DES)
A4103 LAQ824 (NVP-LAQ824,Dacinostat)
1 Citation

Summary: HDAC inhibitor,potent and novel

insoluble in H2O; insoluble in EtOH; ≥17.45 mg/mL
A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A1910 Bromodomain Inhibitor, (+)-JQ1
69 Citation

Target: Bromodomains

Summary: BET bromodomain inhibitor

≥22.85 mg/mL